766. Steps towards the synthesis of the histidine-hypertensin analogue. Part I. Synthesis of an intermediate protected heptapeptide

Theodoropoulos, D; Gazopoulos, J

dc.contributor.author	Theodoropoulos, D	en
dc.contributor.author	Gazopoulos, J	en
dc.date.accessioned	2014-03-01T01:37:38Z
dc.date.available	2014-03-01T01:37:38Z
dc.date.issued	1960	en
dc.identifier.issn	03681769	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/21582
dc.relation.uri	http://www.scopus.com/inward/record.url?eid=2-s2.0-37049044939&partnerID=40&md5=eeaade1d386890d15fda31069495c497	en
dc.title	766. Steps towards the synthesis of the histidine-hypertensin analogue. Part I. Synthesis of an intermediate protected heptapeptide	en
heal.type	journalArticle	en
heal.publicationDate	1960	en
heal.abstract	Histidine, protected in the glyoxaline ring, has been used in the synthesis of the blocked heptapeptides, benzyloxycarbonyl-1 (or 3)-benzyl-L-histidyl-L- valyl-L-tyrosyl-L-isoleucyl-1(or 3)-benzyl-L-histidyl-L-prolyl-L-phenylalanine methyl and benzyl ester. The intermediate tetrapeptide, L-isoleucyl- 1(or 3)-benzyl-L-histidyl-L-prolyl-L-phenylalanine methyl ester di-hydrobromide has been synthesised by two routes, and the products compared by optical rotation.	en
heal.journalName	Journal of the Chemical Society (Resumed)	en
dc.identifier.spage	3861	en
dc.identifier.epage	3865	en